Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BodyLogicMD vs MyFastRx

BodyLogicMD
Graded #254

Lower grade

vs+4.199999999999996
MyFastRx
Graded #161

Higher grade

The verdict

MyFastRx takes it — 67.6/100 to 63.4/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +2
74
76
Dose & formulationMyFastRx +32
40
72
Clinical oversightBodyLogicMD +10
76
66
Labs & monitoringBodyLogicMD +12
64
52
FulfillmentMyFastRx +23
60
83
Contract termsBodyLogicMD +20
61
41
BodyLogicMD · left barMyFastRx · right bar

The numbers

MetricBodyLogicMDMyFastRx
WeighScore63.4/10067.6/100
GradeCC
Scorecard rank#254#161
SemaglutideNot disclosed$169/mo
TirzepatideNot disclosed$249/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
BodyLogicMD

Graded #254 · C

Strengths

  • Established since 2003 with board-certified specialists and a national network of local clinics plus telehealth
  • Integrates GLP-1 weight management with bioidentical hormone therapy and lab-based, whole-person protocols
  • Transparent $79/month membership, no insurance required, cancel anytime

Where it loses points

  • GLP-1 medication cost is not published — only the $79 membership fee is shown; drug type (compounded vs brand) not stated
  • Weight loss is secondary to the hormone-therapy core; not a GLP-1-first telehealth
  • State availability and dispensing pharmacy are not disclosed on the marketing site
MyFastRx

Graded #161 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard